Focused, pre-designed cancer panels relevant for clinical cancer research that allow users to customize content.
- Description
Focused cancer research
A one-size-fits-all approach just doesn’t work for everyone, so we’ve developed a range of Oncomine assays to cover the spectrum of panel sizes and purposes.
Choose Oncomine tumor-specific panels
Ion Torrent Oncomine tumor-specific panels complement Oncomine assays, providing end-to-end solutions for researching the molecular profile of specific tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.
These dynamic panels are created from a curated inventory of pre-tested genes relevant to cancer research and sized to be economical (15–30 genes).
- Available via ampliseq.com and manufactured on demand
- Low sample input requirement and robust performance on FFPE tissue
- End-to-end research workflow, including bioinformatics and a reporting solution
- Specialized support to enable rapid implementation of panels in your lab
Oncomine tumor-specific panels for cancer research
|
Oncomine Bladder Panel
25-gene panel applicable to urothelial carcinoma (~90% of bladder cancers). Contains genes such as PIK3CA, FGFR3, and ERBB2. |
 |
Oncomine Kidney Panel15-gene panel applicable to renal cell carcinomas (the majority of kidney cancers). Contains genes such as VHL, MTOR, and PBRM1 |
 |
Oncomine BRCA Expanded Panel
15-gene panel containing BRCA1 and BRCA2 as well as HR pathway genes important for ovarian, breast, and prostate cancer research. Contains genes such as ATM, PALB2, and BRIP1. |
 |
Oncomine Liver Panel22-gene panel applicable to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Contains genes such as TP53, MYC, TERT, and CTNNB1. |
 |
Oncomine Colorectal and Pancreatic Panel24-gene panel applicable to colorectal and pancreatic adenocarcinoma, including DNA mismatch repair pathway genes. Also contains genes such as APC, KRAS, and NRAS. |
 |
Oncomine Lymphoma Panel25-gene panel applicable to non-Hodgkin’s lymphomas (primarily diffuse large B cell (DLBCL)) as well as to Hodgkin’s lymphoma. Contains genes such as BCL2, MYD88, and CARD11. |
 |
Oncomine Gastric and Esophageal Panel17-gene panel applicable to gastric, esophageal, and gastroesophageal adenocarcinoma. Contains genes such as TP53, ERBB2, and CDKN2A. |
 |
Oncomine Melanoma Panel29-gene panel applicable to cutaneous and uveal melanoma. Contains genes such as BRAF, NRAS, and CDKN2A. |
 |
Oncomine Gynecological Panel19-gene panel applicable to endometrial, cervical, and ovarian carcinomas. Contains genes such as PTEN, BRCA2, and CTNNB1. |
 |
Oncomine Prostate Panel21-gene panel applicable to prostate adenocarcinoma. Contains genes such as AR, PTEN, and MYC. |
 |
Oncomine Tumor Specific RNA Panel49-gene research panel complements the Oncomine tumor specific panels; however, it is not available with the Oncomine Lymphoma Panel. This RNA-only panel uses FusionSync technology to detect known, novel, and rare fusions from even small sample inputs. This panel cannot be customized. |
 |
Oncomine HRR Pathway Predesigned Panel28-gene panel containing homologous recombination repair (HRR) pathway genes. Inclusive of genes found on the Oncomine BRCA Expanded Panel plus additional non-HRR genes such as KRAS and PIK3CA important for ovarian, breast, prostate, and pancreatic cancer research.* *The HRR Pathway Predesigned Panel does not come with a preconfigured Ion Reporter analysis workflow. |
Description
Focused cancer research
A one-size-fits-all approach just doesn’t work for everyone, so we’ve developed a range of Oncomine assays to cover the spectrum of panel sizes and purposes.
Choose Oncomine tumor-specific panels
Ion Torrent Oncomine tumor-specific panels complement Oncomine assays, providing end-to-end solutions for researching the molecular profile of specific tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.
These dynamic panels are created from a curated inventory of pre-tested genes relevant to cancer research and sized to be economical (15–30 genes).
- Available via ampliseq.com and manufactured on demand
- Low sample input requirement and robust performance on FFPE tissue
- End-to-end research workflow, including bioinformatics and a reporting solution
- Specialized support to enable rapid implementation of panels in your lab
Oncomine tumor-specific panels for cancer research
|
|
Oncomine Bladder Panel
25-gene panel applicable to urothelial carcinoma (~90% of bladder cancers). Contains genes such as PIK3CA, FGFR3, and ERBB2. |
|
Oncomine Kidney Panel15-gene panel applicable to renal cell carcinomas (the majority of kidney cancers). Contains genes such as VHL, MTOR, and PBRM1 |
|
|
Oncomine BRCA Expanded Panel
15-gene panel containing BRCA1 and BRCA2 as well as HR pathway genes important for ovarian, breast, and prostate cancer research. Contains genes such as ATM, PALB2, and BRIP1. |
|
Oncomine Liver Panel22-gene panel applicable to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Contains genes such as TP53, MYC, TERT, and CTNNB1. |
|
|
Oncomine Colorectal and Pancreatic Panel24-gene panel applicable to colorectal and pancreatic adenocarcinoma, including DNA mismatch repair pathway genes. Also contains genes such as APC, KRAS, and NRAS. |
|
Oncomine Lymphoma Panel25-gene panel applicable to non-Hodgkin’s lymphomas (primarily diffuse large B cell (DLBCL)) as well as to Hodgkin’s lymphoma. Contains genes such as BCL2, MYD88, and CARD11. |
|
|
Oncomine Gastric and Esophageal Panel17-gene panel applicable to gastric, esophageal, and gastroesophageal adenocarcinoma. Contains genes such as TP53, ERBB2, and CDKN2A. |
|
Oncomine Melanoma Panel29-gene panel applicable to cutaneous and uveal melanoma. Contains genes such as BRAF, NRAS, and CDKN2A. |
|
|
Oncomine Gynecological Panel19-gene panel applicable to endometrial, cervical, and ovarian carcinomas. Contains genes such as PTEN, BRCA2, and CTNNB1. |
|
Oncomine Prostate Panel21-gene panel applicable to prostate adenocarcinoma. Contains genes such as AR, PTEN, and MYC. |
|
|
Oncomine Tumor Specific RNA Panel49-gene research panel complements the Oncomine tumor specific panels; however, it is not available with the Oncomine Lymphoma Panel. This RNA-only panel uses FusionSync technology to detect known, novel, and rare fusions from even small sample inputs. This panel cannot be customized. |
|
Oncomine HRR Pathway Predesigned Panel28-gene panel containing homologous recombination repair (HRR) pathway genes. Inclusive of genes found on the Oncomine BRCA Expanded Panel plus additional non-HRR genes such as KRAS and PIK3CA important for ovarian, breast, prostate, and pancreatic cancer research.* *The HRR Pathway Predesigned Panel does not come with a preconfigured Ion Reporter analysis workflow. |